[HTML][HTML] The use of immune checkpoint inhibitors in oncology and the occurrence of AKI: where do we stand?
Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
[引用][C] The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
R Franzin, GS Netti, F Spadaccino, C Porta… - FRONTIERS IN …, 2020 - fair.unifg.it
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where
Do We Stand? IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie …
Do We Stand? IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie …
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
P Ghezzi, A Saxena, G Ruggiero - Dysfunction of the Immune …, 2022 - books.google.com
Cancer immunotherapy encompasses a number of different treatments aimed at stimulating
the immune system in order to promote the recognition and the elimination of tumor cells (1) …
the immune system in order to promote the recognition and the elimination of tumor cells (1) …
[PDF][PDF] The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand
R Franzin, GS Netti, F Spadaccino… - Front. Immunol. 11 …, 2020 - researchgate.net
Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have
improved the treatment of a broad spectrum of cancers as metastatic melanoma, nonsmall …
improved the treatment of a broad spectrum of cancers as metastatic melanoma, nonsmall …
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
R Franzin, GS Netti, F Spadaccino, C Porta… - FRONTIERS IN …, 2020 - air.unimi.it
Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
R Franzin, GS Netti, F Spadaccino, C Porta… - Frontiers in …, 2020 - europepmc.org
Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
[引用][C] The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
R Franzin, GS Netti, F Spadaccino, C Porta… - Frontiers in …, 2020 - cir.nii.ac.jp
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do
We Stand? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
We Stand? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[HTML][HTML] The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
R Franzin, GS Netti, F Spadaccino, C Porta… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
R Franzin, GS Netti, F Spadaccino… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
R Franzin, GS Netti, F Spadaccino, C Porta… - FRONTIERS IN …, 2020 - ricerca.uniba.it
Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …